Teva Pharmaceutical reported 1.9B in Gross Profit on Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Aspen Pharmacare APN:SJ 8.6B 583M
Cipla CIPLA:IN 33.83B 524M
Dr.Reddys Laboratories DRRD:IN 37.59B 5.16B
Guangzhou Baiy 600332:CH 3.23B 263.87M
Jiangsu Hengrui Me. 600276:CH CH 5.88B 399.7M
Kalbe Farma Tbk Pt KLBF:IJ 2881.92B 131.76B
Richter Gedeon RICHT:HB 85.72B 2.52B
Sh Fosun Pharma 600196:CH CH 4.77B 216.37M
Sun Pharmaceuticals SUNP:IN IR 71040.7M 347.6M
Teva Pharmaceutical TEVA:IT 1.9B 25M